BreakThrough Digest offers current medical news and health articles on medical breakthroughs, medical research and health information on clinical trials,
cancer, Alzheimer's, stem-cell research, heart disease, diabetes and more.
Neprinol - exclusive distributors of pharmaceutical-grade products including neprinol, syntol, and devacor
Chelation - cardio renew is 100% pure edta providing cardiovascular cleansing by oral chelation.
Botulism Treatments & Research in the News
Xoma's 4th-qtr profit falls as contract revenue tumbles ... - Washington Examiner ... is developing a type 2 diabetes treatment, a potential heart drug, and an anti-botulism antibody. The company has contracts and agreements with Takeda Pharmaceutical Company Ltd., Cephalon Inc., and Kaketsuken, a Japanese research foundation.
BOTOX® (OnabotulinumtoxinA) Receives FDA Approval ... - TMCnet ... research and development and regulatory processes; challenges related to product marketing, such as the unpredictability of market acceptance for new products and/or the acceptance of new indications for such products; inconsistency of treatment ...
Epione Medical Corp - PR.com ... consumers are advised to do their research prior to their office visit. BOTOX® is most often used to treat cosmetic based wrinkles and laugh lines on the face. It is derived from botulinum toxin-a, which can cause botulism ... the treatment
Xoma 4Q profit falls as contract revenue tumbles - AP ... - Salon ... is developing a type 2 diabetes treatment, a potential heart drug, and an anti-botulism antibody. The company has contracts and agreements with Takeda Pharmaceutical Company Ltd., Cephalon Inc., and Kaketsuken, a Japanese research foundation.
Epione Ranked #1 on BOTOX® Website - PRLog (free press release) ... consumers are advised to do their research prior to their office visit. BOTOX® is most often used to treat cosmetic based wrinkles and laugh lines on the face. It is derived from botulinum toxin-a, which can cause botulism ... the treatment
BOTOX® (OnabotulinumtoxinA) Receives FDA Approval for ... - PR Inside ... research and development and regulatory processes; challenges related to product marketing, such as the unpredictability of market acceptance for new products and/or the acceptance of new indications for such products; inconsistency of treatment ...
FDA Approves Botox for Elbow Spasms. Are Migraines Next ... - Daily Finance ... the FDA's Center for Drug Evaluation and Research ... those of botulism, including potentially life-threatening difficulty with swallowing and breathing. The FDA further stressed that Botox has not been proved a safe, effective treatment for ...
BOTOX(R) (OnabotulinumtoxinA) Receives FDA Approval for ... - StreetInsider.com ... research and development and regulatory processes; challenges related to product marketing, such as the unpredictability of market acceptance for new products and/or the acceptance of new indications for such products; inconsistency of treatment ...
Spasticity in flexor muscles of elbow, wrist, and ... - News-Medical.Net director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research. "In clinical trials, treatment with Botox was ... of the body, causing symptoms similar to those of botulism . Those symptoms include swallowing and ...
BreakThrough Digest Copyright 2007 BreakThrough Digest BreakThrough Digest subscribes to the eHealth Code of Ethics
medical new and medical breakthroughs health information and health articles about medicine on cancer, heart disease, diabetes and stem cell research
